Rallybio
RLYB
NASDAQ
IPO2021
about RLYB
Rallybio is a biopharmaceutical company focused on identifying and developing innovative therapies for patients.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $9.62 | $11.20 | $9.35 | $39.81M | 3.66M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.36 | n/a | 2265.68 | -3266.51% | 7554.72% | 0% |